VMP 42271811000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Fluoxetine 20mg/5ml oral solution
BNF code 0403030E0AAACAC
Virtual Therapeutic Moiety Fluoxetine
Date identifier became valid 22 Sep 2023
Previous product identifier 321951005
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 5.000
Unit dose form units ml
Unit dose unit of measure spoonful
Virtual Product Ingredient
Ingredient Fluoxetine hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372767007
Strength value numerator 4.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solution.oral
Dose Form
Formulation Oral solution
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Fluoxetine 20mg/5ml oral solution (A A H Pharmaceuticals Ltd)
Fluoxetine 20mg/5ml oral solution (Alliance Healthcare (Distribution) Ltd)
Fluoxetine 20mg/5ml oral solution (Almus Pharmaceuticals Ltd)
Fluoxetine 20mg/5ml oral solution (Kent Pharma (UK) Ltd)
Fluoxetine 20mg/5ml oral solution (Medihealth (Northern) Ltd)
Fluoxetine 20mg/5ml oral solution (Phoenix Healthcare Distribution Ltd)
Fluoxetine 20mg/5ml oral solution (Pinewood Healthcare)
Fluoxetine 20mg/5ml oral solution (Relonchem Ltd)
Fluoxetine 20mg/5ml oral solution (Sigma Pharmaceuticals Plc)
Fluoxetine 20mg/5ml oral solution (Thame Laboratories Ltd)
Virtual Medicinal Product Packs
Fluoxetine 20mg/5ml oral solution 1 ml
Fluoxetine 20mg/5ml oral solution 70 ml

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback